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Purpose: The purpose of this research was to
examine associations among 2 separate Minimum
Data Set-Home Care (MDS-HC) depression measures (the Depression Rating Scale [DRS] and medical
diagnosis of depression) with billed antidepressant
medications in Medicaid paid claim files. Design
and Methods: The sample for this cross-sectional research included 3,041 Medicaid-eligible
older adult participants in a Home and Community
Based Waiver Program and used data from the
MDS-HC, Version 1 and Medicaid Paid Claim Files.
Sensitivity and specificity analyses, receiver operating characteristic (ROC) curve analysis, and t tests
were utilized. Results: DRS scoring indicated
that 15.4% of participants had behaviors indicative
of depression, whereas 42% had a medical diagnosis of depression noted in the MDS-HC. Of those
with a medical diagnosis of depression, 51% had a
prescribed antidepressant medication. ROC analysis
suggested that the DRS was a poor distinguisher of
participants with and without a medical diagnosis
of depression or prescribed antidepressant medications. Implications: Approximately half of
Medicaid-eligible older adults medically diagnosed
with depression were treated pharmacologically.
Longitudinal research is recommended to assess
responsiveness of the DRS over time to pharmacological and psychotherapeutic interventions for depression.

Key Words: Home and Community Based Services,
Measurement, Mental health (services, therapy),
Medicaid/Medicare, Depression

Depression is widely under-recognized and
undertreated among older adults and should not
be considered a normal part of aging (National
Institute of Mental Health, 2007). Approximately
7 million adults aged 65 and older are affected by
depression (Steinman et al., 2007), with 8%–16%
of community-dwelling older adults experiencing
clinically significant depressive symptoms (Blazer,
2003). Depression frequently co-occurs with other
chronic diseases and is associated with increased
health care utilization, greater pain, lower quality of
life, increased risk of suicide, and diminished physical
functioning among older adults (Blazer, 2003; Bruce
et al., 2002; Gellis, 2009, 2010). Despite the prevalence
and poor outcomes of depression among older adults,
the negative stigma of mental illness may prevent
older adults from seeking professional treatment for
depression (Zartaloudi & Madianos, 2010).
Professional treatment of depression in older
adults may consist of pharmacological and/or psychotherapeutic interventions. Psychotherapeutic
treatments for depression include cognitive
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and a 27% use of antidepressants (Li & Conwell,
2007). The results of Li and Conwell (2007) suggest higher rates of depression among Medicaideligible older adults receiving home care services
(33%) when compared with rates of depression
among other populations of older adults receiving
home care services (13.5%; Bruce et al., 2002).
Previous research examining depression and
treatment of depression among Medicaid-eligible
older adults receiving home care services has several limitations that this research addressed. First,
to document antidepressant use, Li and Conwell
(2007) used a single Minimum Data Set HomeCare (MDS-HC) item that documented whether
antidepressants were taken in the last 7 days and
coded as yes/no. General concerns about data
accuracy (both overreporting and underreporting)
in the Minimum Data Set (MDS) have been noted
(Rahman & Applebaum, 2009; Shin & Scherer,
2009), and therefore, a complete representative
use of antidepressant medication use may not have
been captured. In this research, we instead utilized
Medicaid paid claim file pharmacy data to examine the use of antidepressant medications among
older adult HCBWP participants.
Second, the validity and reliability of an MDS
depression-related item for use with older adult
nursing home residents have been questioned
and additional research has been recommended
(Anderson, Buckwalter, Buchanan, Maas, &
Imhof, 2003; Liang et al., 2011). Anderson and
colleagues (2003) found that the MDS Depression
Rating Scale (DRS) performed poorly among
older adult nursing home residents (n = 145)
when correlated with the Geriatric Depression
Scale (r = .13), the Hamilton DRS (r = .24), and
charted medical diagnosis of depression (r = .31).
Liang and colleagues (2011) compared differences
in the rate of depression among institutionalized
older Chinese men (n = 595) via the DRS and the
Geriatric Depression Scale (GDS). The rate of
depression according to the DRS was only 0.2%,
whereas the rate of depression with the GDS was
8.7%. Liang and colleagues concluded that the
effectiveness of the DRS as a screening instrument
for depression among older adults may be limited.
In summary, the earlier research results suggest
that the DRS may not be as sensitive and specific
as alternative measures in detecting depression
among older adults. Therefore, this research will
compare the DRS to other indicators of depression
in the MDS-HC and Medicaid drug paid claim files
to further examine the validity of the DRS.
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behavior therapy, psychoeducation, psychotherapy, reminiscence/life review, physical exercise, and
problem-solving therapy (Cuijpers, van Straten, &
Smit, 2006). Psychotherapeutic interventions used
alone or together with pharmacological interventions can lead to improved patient outcomes
including mood, emotional distress, and physical functioning (Cuijpers et al., 2006; Pinquart,
Duberstein, & Lyness, 2007). Nonetheless, a trend
analysis of Medicare Current Beneficiary Survey
Data (1992–2005) has suggested that pharmacotherapy is assuming a more prominent role in
the treatment of depression among older adults
(Akincigil et al., 2011). Access to appropriate
mental health services and improvements in the
health, function, and quality of life of older adults
have been prioritized by Healthy People 2020
(U.S. Department of Health & Human Services,
2010) and the Centers for Disease Control and
Prevention (Benson & Aldrich, 2011). With the
establishment of these guidelines for high-quality
mental health care, there is a clear need to examine
the occurrence and treatment of depression among
older adults.
Health care services for older adults can be
viewed as a continuum, moving from community
to institutionalization. An alternative to institutionalization for older adults is to receive care services at home. The prevalence and undertreatment
of depression among community-dwelling older
adults receiving home care services is concerning.
Bruce and colleagues (2002) noted that among
older adults receiving home care services (n = 539),
13.5% were diagnosed with major depression, of
which only 22% were receiving antidepressant
medication. Similarly, Gellis, McGinty, Horowitz,
Bruce, and Misener (2007) found that only 12% of
older adults receiving home care services and diagnosed with major depression received adequate
antidepressant treatment (n = 40).
Older adults who receive home care services
through a Medicaid Home and Community Based
Waiver Program (HCBWP) may be at higher
risk for undertreatment of depression than other
community-dwelling older adults. HCBWP participants are assumed to be impoverished because
they are Medicaid eligible. Older adults who live
at or below the poverty line have higher rates of
depression than community-dwelling older adults
living above the poverty line (Gum, Arean, &
Bostrum, 2007). Previous research examining mental health among older adult HCBWP participants
(n = 18,939) found a 33% occurrence of depression

or the caregiver or family member of the participant if the participant was not capable of responding. Observations of the participant and medical
record reviews were also made by the assessor.
For this research, we completed cross-sectional
analyses on MDS-HC data from the second
assessment for those participating in MIChoice.
The data also included Medicaid paid claim file
pharmacy data for 60 days prior to the second
MDS-HC assessment. We selected a 60-day time
period because preanalyses suggested that 99%
of the prescribed antidepressant medications
(any one antidepressant present—yes/no) were
captured within a 60-day time period between
assessments. We did not use a 90-day time
period because approximately half of the second
MDS-HC assessments occurred less than 90 days
after the previous (first) assessment, which would
have resulted in the inclusion of Medicaid paid
claim file data that was before the previous (first)
MDS-HC assessment.

1.

The study was granted exempt status by the
Michigan Department of Community Health
(MDCH) Institutional Review Board and the
Michigan State University Institutional Review
Board, as the study was a secondary analysis of
de-identified data. Data use and nondisclosure
agreements were completed by the researcher as
required by the MDCH. Specific measures used
in the research are described in the following
paragraphs.

2.
3.
4.

What is the prevalence of behaviors indicative
of depression, as noted by the DRS?
What is the prevalence of medically diagnosed
depression?
What is the prevalence of prescribed antidepressant medications?
How do behaviors indicative of depression, as
noted by the DRS, associate with the medical
diagnosis of depression and prescribed antidepressant medications?

Methods
The sample (N = 3,041) was a subset from a
larger longitudinal study that examined pain, pain
management, and pain management outcomes
among older adults aged 65 and older who participated in the Michigan Medicaid HCBWP,
known as MIChoice, between January 1, 2002
and December 31, 2005. The MIChoice program
allowed Medicaid-eligible older adults to receive
care services in their homes instead of being admitted to a nursing home for similar care services.
Assessments of MIChoice participants were completed using the MDS-HC Version 1 assessment
tool on admission to MIChoice and approximately
every 90 days thereafter. The MDS-HC items consisted of questions that were primarily asked by
a trained assessor of the participant (if possible)

Procedures

Depression Rating Scale.—We used the DRS
to represent the presence of behaviors that were
indicative of depression. The DRS corresponded to
the HCBWP participant or proxy observation of
the HCBWP participant exhibiting in the 30 days
prior to assessment feelings of sadness, persistent
anger, repetitive anxious complaints, sad facial
expressions, recurrent crying, and withdrawal from
activities of interest. The responses were summed to
create a possible score of 0–12, with a higher score
evident of more behaviors indicative of depression.
A DRS score greater than 3 is considered indicative
of depression (Burrows, Morris, Simon, Hirdes, &
Phillips, 2000; Li & Conwell, 2007). As such, the
DRS score may also be dichotomized as 0 or 1, with
0–2 = 0 as not indicative of depression and a DRS
score greater than 3 = 1 as indicative of depression
(Burrows et al., 2000; Li & Conwell, 2007).
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Although there are multiple measures of depression within the MDS-HC, previous research has
not explored associations between them. Measures
are used to take note of the presence of specific
signs or symptoms of disease manifested in the
patient. Symptoms are conceptualized as “…
important cues that bring problems to the attention of patients and clinicians” (Dodd et al.,
2001, p. 669). Regarding depression, symptoms
are patient behaviors that indicate the presence
of depression for diagnostic purposes. Within the
symptom management model (SMM; Dodd et al.,
2001), the symptom experience, management, and
management outcomes are in continual interaction
with each other as well as with personal, health
and illness, and environmental factors. For this
research, we utilized the SMM to conceptualize
associations between indicators of depression and
prescribed antidepressant medications within the
HCBWP environment.
This research was guided by the following
research questions. Among Medicaid-eligible,
community-dwelling older adults

Prescribed Antidepressant Medications.—We
utilized the measure of prescribed antidepressant
medications to represent the presence of prescribed
antidepressant medications in the Medicaid paid
claim files in the 60-day time period before the
MIChoice participant’s second MDS-HC assessment. We ascertained the 60-day time period
through the use of the “claim service begin date,”
which is the start date for each particular claim
and is considered the date of service for purchasing
the antidepressant medication.
Vol. 53, No. 4, 2013

We searched the Medicaid paid claim files
pharmacy data within the 60 days prior to the
MDS assessment date using the claim service
begin date, preexisting drug class coding, as well
as searches for specific antidepressant medication. Selective serotonin reuptake inhibitors and
serotonin–norepinephrine reuptake inhibitors are
considered mainstays of pharmacological treatment of depression among older adults (Swenson
et al., 2003). Antidepressant medications included
in the search were bupropion, citalopram, venlafaxine, fluoxetine, fluvoxamine, escitalopram,
paroxetine, and sertraline (Burnett-Zeigler et al.,
2012). Tricyclic and other cyclic antidepressants
were excluded as they are frequently used to
treat other conditions such as chronic pain and
as a sleep aid (Burnett-Zeigler et al., 2012). Final
coding for the measure was 0 = no prescribed
antidepressant medications and 1 = prescribed
antidepressant medications in the 60 days prior
to the MDS-HC assessment.
We analyzed the data using PASW v.18. Tests
had a 0.05 set level of significance. We utilized
descriptive and predictive methods to characterize
participants. Chi-square, sensitivity and specificity,
receiver operating characteristic (ROC) curve, and
t-test analyses were used to explore associations
among the DRS, medical diagnosis of depression,
and prescribed antidepressant medications.
Results
We completed the analyses on 3,041 participants. Women comprised 81% of the sample.
Participant’s age at the time of assessment ranged
from 65 to 102 years, with a mean age of 78
(SD = 7.53). The sample was 78% Caucasian,
19% African American, 0.01% Hispanic, and
3% “other.” “Other” (n = 68) was comprised of
American Indian (n = 3), Asian and Pacific Islander
(n = 9), and unknown (n = 56).
Research Question 1
Depression Rating Scale.—Utilizing the
dichotomized DRS cutoff criteria of greater
than 3 as described earlier, 15.4% of participants exhibited behaviors that were indicative
of depression. Cronbach’s alpha for the DRS
was 0.74 for this study. The sample DRS scores
ranged from 0 to 12, with a mean score of 1.05
(SD = 1.75) and median of 0. Participant age and
mean DRS score were significantly associated
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Medical Diagnosis of Depression.—We developed the measure of medical diagnosis of depression using questions 7 and 9 of the MDS-HC
section I. Question 7 assessed for presence of
health care provider-diagnosed depression in
the participant’s medical record with possible
responses as 0 = not present; 1 = present, not subjected to focused treatment or monitoring by home
care nurse; and 2 = present, monitored or treated
by home care nurse. We then recoded the original
responses as 0 = depression diagnosis not present
and 1 = depression diagnosis present.
Question 9 allowed the MDS-HC assessor to enter in specific International Statistical
Classification of Diseases-9 (ICD-9) codes for
diagnoses not addressed or not addressed fully in
question 7. We searched question 9 data for the
presence of the ICD-9 coding for the following conditions: “major depression single episode” (296.2),
“major depression recurrent” (296.3), “depression
not otherwise specified” (311), “prolonged depressive reaction” (309.1), and “dysthymia” (300.4).
Information regarding the ordering health care
provider, diagnostic criteria used by the provider, or
length of time of the diagnosis prior to entering the
MIChoice program was not available in the data.
We then combined the responses from MDS-HC,
section I, questions 7 and 9 to create a new measure, which denoted if the participant had a medical
diagnosis of depression in the MDS-HC. If either
or both of the participant’s MDS-HC question 7
or 9 responses were positive for the presence of a
medical diagnosis of depression, then the response
for the new measure was “yes.” If both of the
responses for the participant’s response to questions 7 and 9 were “no,” then the response for the
new measure was “no.” Final coding for the measure of medical diagnosis of depression was 0 = no
medical diagnosis of depression and 1 = medical
diagnosis of depression.

Research Question 2
Medical Diagnosis of Depression.—Descriptive
analysis of the measure of medical diagnosis of
depression revealed that 42% of the participants
had a diagnosis of depression documented in
either question 7 or question 9 of section I of the
MDS-HC. Thirteen percent of participants who
had a diagnosis of depression documented from
question 7 also had a depression-related ICD-9
code documented from question 9, indicating little
overlap of the two measures. Although low, this
was not of major concern as the purpose of question 9 was to capture ICD-9 coding for additional
diagnoses not already covered in question 7.
Separate simple logistic regression models were
used to assess for differences in the odds of having
a medical diagnosis of depression in regards to age,
sex, and race. As age increased, the odds of having a medical diagnosis of depression significantly
decreased (β = −0.38, SE = 0.005, p < .001). We did
not find a significant difference in the odds of having a medical diagnosis of depression in regards to
sex. Participants who self-identified with the race
group “other” experienced significantly decreased
odds of having a medical diagnosis of depression when compared with Caucasian participants
(β = −1.12, SE = 0.38, p = .004).
Research Question 3
Prescribed Antidepressant Medications.—Among
the sample, 27.5% of participants had a prescribed
antidepressant medication in the Medicaid paid claim
files in the 60 days prior to the MDS-HC assessment.
We discovered that participants had multiple episodes of prescribed antidepressant medication within
the 60-day period, for a total of 1,640 billed antidepressant medication episodes among the 837 participants with billed antidepressant medication. The

four most frequently billed antidepressant medications were paroxetine (n = 462), sertraline (n = 438),
fluoxetine (n = 284), and citalopram (n = 231).
The mean age of participants who had a prescribed antidepressant medication (76.10 years)
was significantly (p < .001) younger than the mean
age of participants with no prescribed antidepressant medication (78.10 years). We did not find a
significant difference between male and female
participants in the odds of having a prescribed
antidepressant medication. In regards to race, participants who self-identified with the race group,
“others” (American Indian, unknown, Asian, and
Pacific Islander; n = 68) experienced significantly
lower odds of having a prescribed antidepressant
medication when compared with Caucasian participants (β = −1.40, SE = 0.40, p = .001).
Because of the close clinical association between
the prescription of antidepressant medications
and a medical diagnosis of depression, we completed chi-square testing to determine the statistical association between the measures of medical
diagnosis of depression and prescribed antidepressant medication. Whether a participant had a
medical diagnosis of depression had a significant
effect on whether a participant would or would
not have a prescribed antidepressant medication
(X2 = 607.12, df = 1, p < .001), prescribing antidepressant medications by a health care provider
would logically be preceded by a medical diagnosis of depression in the clinical setting and would
therefore support a strong association between the
measures of medical diagnosis of depression and
prescribed antidepressant medications.
Nonetheless, of the participants who had a
medical diagnosis of depression (n = 1,277), only
51% had a prescribed antidepressant medication
in the 60 days prior to assessment, suggesting that
almost half of all older adult HCBWP participants
with a medical diagnosis of depression did not
receive pharmacotherapy (Table 1). There are
several alternative explanations for the absence of
prescribed antidepressant medications. The absence
of antidepressant medications may have been due to
a failed previous trial of antidepressant medications,
a circumstance that was not captured in the data.
Alternatively, medically diagnosed participants
without a prescribed antidepressant may have been
receiving psychotherapeutic interventions for their
depression instead of pharmacotherapy and this
information was also not contained in the data.
Psychotherapeutic interventions are more preferred
than pharmacological interventions by older primary

612

The Gerontologist

Downloaded from https://academic.oup.com/gerontologist/article/53/4/608/556958 by Calvin College / Hekman Library user on 04 June 2022

such that as participant age increased, the mean
DRS score decreased (β = −0.017, p < .001). We
found no significant difference in mean DRS score
in regards to sex. There was a significant difference in the mean DRS score in regards to race
(F = 5.86, df = 3, p = .001). When compared with
Caucasian participants, African Americans participants had a significantly decreased mean DRS
score (β = −0.33, SE = 0.08, p < .001), indicating less behaviors indicative of depression. Race
groups such as “other” and Hispanic did not have
a significantly different mean DRS score when
compared with Caucasian.

Table 1. Cross-tabulation of Medical Diagnosis of
Depression and Prescribed Antidepressant Medications

Table 2. Cross-tabulation of the Dichotomized Depression
Rating Scale (DRS) Score and Medical Diagnosis of
Depression

Prescribed antidepressant
medication
t

Yes (%)

Total

1578 (72)

186 (22)

1,764

626 (28)

651 (78)

1,277

837

3,041

2204

Dichotomized DRS score

care patients (Gum et al., 2006). Drug interactions
are a valid concern of health care providers given
that the average prescription medication count
of community-dwelling older adults is seven
medications (Orwig, Brandt, & Gruber-Baldini,
2006). The use of psychotherapeutic interventions
for depression instead of antidepressant medications
may therefore decrease the risk of drug interactions
among older adults.
One could theorize that if a participant was on an
antidepressant medication, then he or she may have
less behaviors indicative of depression (as measured
by the DRS) because symptoms or behaviors would
be minimized by the use of an antidepressant medication. To test this theory, we carried out a t-test
analysis to determine if there was a difference in the
mean DRS score among participants with a medical diagnosis of depression in regards to the presence
of prescribed antidepressant medications. Among
participants with a medical diagnosis of depression,
there was no significant difference in mean DRS
score between those with and without a prescribed
antidepressant medication. Interestingly, the mean
DRS scores for participants who had a medical diagnosis of depression and prescribed antidepressant
medications was 1.52, whereas participants who
had a medical diagnosis of depression and had no
prescribed antidepressant medications was 1.55—
below the DRS cutoff of greater than 3 as indicative
of depression (Burrows et al., 2000). However, those
with a medical diagnosis of depression and no prescribed antidepressant medication could have been
receiving psychotherapeutic interventions instead,
which could account for a low DRS score.
Research Question 4
DRS and Medical Diagnosis of Depression.—
Finally, we conducted sensitivity and specificity analyses to answer the fourth research
question. First, the measure of medical diagnosis
Vol. 53, No. 4, 2013

No (%)

Yes (%)

Total

0 = not indicative of
1,599 (91)
972 (76)
depression
1 = indicative of depression 165 (9)
304 (24)
Total
1,764
1,276

2,571
469
3,040

of depression was used as the standard for disease
status and the dichotomized DRS score was used
as the test for the disease of depression in a crosstabulation (Table 2). To review, the DRS score was
dichotomized as 0 (DRS score 0–2) and 1 (DRS
score >3) with a DRS score of greater than 3 as
indicative of depression (Burrows et al., 2000; Li
& Conwell, 2007). The percentage of false positives was 76% and percentage of false negatives
was 9%.
The sensitivity of the dichotomized DRS was
0.24 and specificity was 0.91 in relation to the
medical diagnosis of depression. An ROC analysis
was then completed (Figure 1). Results suggested
that the dichotomized DRS was able to distinguish
between participant with and without a medical
diagnosis of depression significantly better then
chance alone (p < .001). However, the computed
area under the curve (AUC) was 0.57 (95% CI
[0.55, 0.59]), meaning that the dichotomized
DRS was a poor distinguisher of whether a participant did or did not have a medical diagnosis of
depression (Zhu, Zeng, & Wang, 2010). Utilizing
the continuous version of the DRS (0–12, with a
higher score indicating more behaviors indicative
of depression) instead of the dichotomized version
as the test in the ROC analysis only increased the
AUC to 0.62 (95% CI [0.60, 0.65]), which still
indicated poor performance (Zhu et al., 2010).
The positive predictive value (PPV) of the
dichotomized DRS in relation to a medical diagnosis of depression was 65%. Practically, this meant
that among participants who tested positive for
depression per the dichotomized DRS, 35% were
predicted to actually not have a medical diagnosis
of depression. The negative predictive value (NPV)
of the dichotomized DRS in relation to medical
diagnosis of depression was 62%, or 38% of participants who tested negative for depression via the
dichotomized DRS were predicted to actually have
a medical diagnosis of depression.
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0 = no medical diagnosis
of depression
1= medical diagnosis of
depression
Total

No (%)

Medical diagnosis of
depression

DRS and Prescribed Antidepressant Medi
cations.—Next, we used the measure of prescribed
antidepressant medications as the standard for
disease status with the dichotomized DRS as the
test for the disease of depression in a cross-tabulation (Table 3). The percentage of false positives
was 78% and percentage of false negatives was
13%. The sensitivity of the dichotomized DRS in
relation to the measure of antidepressant medication was 0.22 and specificity was 0.87. An ROC
analysis was completed next (Figure 2). Results
suggested that the dichotomized DRS was able to
distinguish between participants with and without
prescribed antidepressant medications significantly
better then chance alone (p < .001). The computed
AUC was 0.54 (95% CI [0.52, 0.57]), indicating
again that the dichotomized DRS was a poor distinguisher of whether a participant did or did not
have prescribed antidepressant medications (Zhu
et al., 2010). Utilizing the continuous version of
the DRS instead of the dichotomized version as the
test in the ROC analysis only increased the AUC
to 0.58 (95% CI [0.56, 0.60]), still indicating poor
performance (Zhu et al., 2010).
The PPV of the dichotomized DRS in relation
to prescribed antidepressant medications was 39%
and was interpreted to mean that among participants who tested positive for depression per the
dichotomized DRS, 61% were predicted to actually
not have depression, as indicated by the presence of
prescribed antidepressant medications. The NPV
of the dichotomized DRS in relation to prescribed

Table 3. Cross-tabulation of the Dichotomized Depression
Rating Scale [DRS] Score and Prescribed Antidepressant
Medications

Dichotomized DRS
score

Prescribed antidepressant
medication
No (%)

0 = Not indicative of 1,919 (87)
depression
1 = indicative of
285 (13)
depression
Total
2,204

Yes (%)

Total

652 (78)

2,571

184 (22)

469

836

3,040

antidepressant medications was 75%, or 25% of
participants who tested negative for depression via
the dichotomized DRS were predicted to actually
have depression, as indicated by the presence of
prescribed antidepressant medications.
Discussion
The results of the sensitivity and specificity
analyses of the DRS were remarkably consistent
when using either the medical diagnosis of depression or prescribed antidepressant medications as
the standard for disease status. The percentages of
false positives were especially striking, as approximately three quarters of those who were indicated
as having depression via the DRS did not actually
have depression, as indicated by either a medical
diagnosis of depression or a prescribed antidepressant medication. On the other hand, the DRS had
a high specificity (0.91 and 0.87) when using either
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Figure 1. Receiver operating characterization (ROC) curve for dichotomized Depression Rating Scale (DRS) as test and medical
diagnosis of depression as disease state.

the medical diagnosis of depression or the prescribed antidepressant medications as the standard for disease status, suggesting that the DRS was
able to correctly identify most of the participants
who did not have behaviors indicative of depression as noted by the DRS.
Similarly, the NPV of the DRS was stronger on
average than the PPV. The NPV results suggested
that the DRS had a higher likelihood of predicting
which participants did not actually have depression (as indicated by not having either a medical
diagnosis of depression or prescribed antidepressant medications) among participants without
behaviors indicative of depression. Additionally,
the ROC analysis indicated that the DRS was a
poor predictor of a medical diagnosis of depression or a prescribed antidepressant medication. In
summary, these analyses of the DRS suggested that
the DRS may be better at corroborating or supporting an already negative diagnosis of depression than distinguishing between persons with and
without depression. However, the ROC analyses
presented the DRS as a poor predictor of a medical
diagnosis of depression or a prescribed antidepressant medication.
The mean DRS score of 1.55 of those with a
medical diagnosis of depression but no prescribed
antidepressant medications was below the cutoff
of greater than 3 to be indicative of depression,
according to DRS guidelines (Burrows et al., 2000;
Li & Conwell, 2007). Additionally, the insignificant
differences in the mean DRS between medically
diagnosed participants with and without a prescribed
Vol. 53, No. 4, 2013

antidepressant medication further question the sen
sitivity of the DRS. Anderson and colleagues (2003)
noted concerns about the ability of an MDS assessor
to recognize behaviors indicative of depression.
Liang and colleagues (2011) suggested that because
the MDS relies heavily on verbal expression, the
DRS may not be able to effectively screen for
depression among older adults, particularly among
older adults who may be reluctant to discuss mood.
Thus, training that educates assessors regarding how
to recognize behaviors indicative of depression as
well as alternative questioning techniques may have
an impact on the sensitivity of the DRS. Although
the results of this research call into question the
reliability and validity of the DRS as have other
researchers (Anderson et al., 2003; Liang et al.,
2011), caution must be exercised as this research
did not examine the effect of psychotherapeutic
interventions on behaviors indicative of depression.
Longitudinal research examining changes in the DRS
in response to diagnosis and pharmacological and
psychotherapeutic treatment of depression would be
helpful in determining the usefulness of the DRS.
The measure of the medical diagnosis of depression indicated that 42% of older adult HCBWP
participants had a diagnosis of depression. This
prevalence is higher than previous research that
has varied from 16% to 33% (Blazer, 2003; Li
& Conwell, 2007). Specifically, Li and Conwell
(2007) examined mental health among older adult
HCBWP participants and found a 33% prevalence
rate of depression. The higher rate found in this
research may be explained in part because data
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Figure 2. Receiver operating characterization (ROC) curve for dichotomized Depression Rating Scale (DRS) as test and prescribed antidepressant medications as disease state.

other Medicaid-eligible older adult population may
therefore be limited.
Conclusion
As research funding opportunities continue to
dwindle, secondary analysis of preexisting data
are an attractive alternative. However, there may
be multiple measures of the same concept in these
data sets. Research is needed to clarify the use of
these concepts to determine relationships between
variables and their overall validity. If these measures are found to be invalid, research results will
be questionable. Future research is needed not
only to establish item validity for the purposes of
research, but also clinical validity and usefulness.
If validity is determined to be poor, then revisions
of MDS-HC items must be supported at policy,
administration, and clinical levels.
The purpose of this cross-sectional research
was to examine associations among two separate
MDS-HC depression measures (the DRS and medical diagnosis of depression) with the presence of
antidepressant medications in Medicaid paid claim
files. Depression may be undertreated pharmacologically in Medicaid-eligible older adults receiving Home and Community Waiver services, as only
half of those with a medical diagnosis of depression had prescribed antidepressant medications.
Longitudinal research examining changes in the
DRS in response to medical diagnosis of depression and both pharmacological and psychotherapeutic treatment of depression would be beneficial
in determining the validity of the DRS.
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